• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.

作者信息

Kirby B, Marsland A M, Carmichael A J, Griffiths C E

机构信息

Dermatology Centre, University of Manchester, Hope Hospital, Salford, Manchester, UK.

出版信息

Clin Exp Dermatol. 2001 Jan;26(1):27-9. doi: 10.1046/j.1365-2230.2001.00753.x.

DOI:10.1046/j.1365-2230.2001.00753.x
PMID:11260172
Abstract

Plaques of psoriasis contain increased levels of cytokines, including tumour necrosis factor-alpha (TNF-alpha), which are thought to be essential to the maintenance of the psoriatic process. We report the successful treatment of severe, recalcitrant psoriasis when infliximab (a monoclonal antibody to TNF-alpha) was used in combination with methotrexate.

摘要

相似文献

1
Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
Clin Exp Dermatol. 2001 Jan;26(1):27-9. doi: 10.1046/j.1365-2230.2001.00753.x.
2
Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis.低剂量英夫利昔单抗联合甲氨蝶呤治疗慢性顽固性银屑病的持续疗效
Dermatol Online J. 2005 Dec 1;11(3):21.
3
Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
Arch Dermatol. 2003 Jul;139(7):949-50. doi: 10.1001/archderm.139.7.949.
4
Infliximab: efficacy in psoriasis.英夫利昔单抗:治疗银屑病的疗效。
Indian J Dermatol Venereol Leprol. 2013 Jul;79 Suppl 7:S25-34. doi: 10.4103/0378-6323.115525.
5
Long-term management of generalized pustular psoriasis with infliximab: case series.英夫利昔单抗治疗泛发性脓疱型银屑病的长期管理:病例系列
J Cutan Med Surg. 2008 Jul-Aug;12(4):184-8. doi: 10.2310/7750.2008.07036.
6
[Infliximab. Role in the treatment of psoriasis].[英夫利昔单抗。在银屑病治疗中的作用]
Hautarzt. 2005 Sep;56(9):831-2, 834-8. doi: 10.1007/s00105-005-1005-7.
7
Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review.英夫利昔单抗治疗120例银屑病患者至少一年的疗效回顾
J Drugs Dermatol. 2011 May;10(5):539-44.
8
Infliximab in psoriasis and psoriatic arthritis.英夫利昔单抗治疗银屑病和银屑病关节炎。
BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638.
9
The effectiveness of tumor necrosis factor alpha antibody (infliximab) in treating recalcitrant psoriasis: a report of 2 cases.肿瘤坏死因子α抗体(英夫利昔单抗)治疗顽固性银屑病的疗效:2例报告
Arch Dermatol. 2002 May;138(5):644-8. doi: 10.1001/archderm.138.5.644.
10
Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.银屑病及其通过英夫利昔单抗介导的肿瘤坏死因子α阻断治疗。
Dermatol Clin. 2004 Oct;22(4):437-47, ix. doi: 10.1016/j.det.2004.03.011.

引用本文的文献

1
Use of biologic agents in combination with other therapies for the treatment of psoriasis.生物制剂与其他疗法联合用于治疗银屑病。
Am J Clin Dermatol. 2014 Dec;15(6):467-78. doi: 10.1007/s40257-014-0097-1.
2
Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.生物制剂治疗银屑病:全面的循证基础科学和临床综述,以及结核病监测的实用指南。
Clin Rev Allergy Immunol. 2013 Apr;44(2):121-40. doi: 10.1007/s12016-012-8301-7.
3
The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities.
肿瘤坏死因子抑制剂在银屑病治疗中的作用:对相关合并症的新启示。
F1000 Med Rep. 2009 May 8;1:30. doi: 10.3410/M1-30.
4
Biological therapy of psoriasis.银屑病的生物治疗
Indian J Dermatol. 2010 Apr-Jun;55(2):161-70. doi: 10.4103/0019-5154.62754.
5
Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.银屑病和银屑病关节炎中的肿瘤坏死因子-α:临床、遗传学及组织病理学视角
Curr Rheumatol Rep. 2004 Aug;6(4):292-8. doi: 10.1007/s11926-004-0041-0.